Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 2/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.31 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.31 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9908154 | 0.83 | KDM4E (0.30) | KDM4EALDH1A1HSD17B10ALOX15 | |
| SCHEMBL9908167 | 0.71 | PRSS1 (0.31) | — | |
| SCHEMBL13103021 | 0.71 | MTNR1A (0.31) | — | |
| SCHEMBL9908189 | 0.70 | — | — | |
| SCHEMBL9908200 | 0.62 | FLT1 (0.34) | PTGER4HSD17B10 | |
| SCHEMBL16232682 | 0.57 | GLA (0.35) | KDM4EALDH1A1HSD17B10GLAGAA | |
| SCHEMBL14849544 | 0.56 | TTPA (0.49) | — | |
| SCHEMBL9908203 | 0.55 | KEAP1 (0.34) | HSD17B10 | |
| SCHEMBL7414900 | 0.53 | PTGER1 (0.50) | PTGER1PTGER4PTGER3PTGER2ALDH1A1 | |
| SCHEMBL13694508 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8197758-B2 | Bodipy fluorophore dyes useful in the labeling and identification of proteins; highly soluble | MONTANA STATE UNIVERSITY (US) | 2012-06-12 | — | — | US | disclosed |
| US-8197759-B2 | Bodipy fluorophore dyes useful in the labeling and identification of proteins; highly soluble | MONTANA STATE UNIVERSITY (US) | 2012-06-12 | — | — | US | disclosed |
| US-7833799-B2 | Zwitterionic dyes for labeling in proteomic and other biological analyses | MONTANA STATE UNIVERSITY (US) | 2010-11-16 | — | — | US | disclosed |
| US-20100203645-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANAYLSES | NATIONAL SCIENCE FOUNDATION | 2010-08-12 | — | — | US | disclosed |
| US-20100036133-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANALYSES | MONTANA STATE UNIVERSITY (US) | 2010-02-11 | — | — | US | disclosed |
| US-7582260-B2 | Zwitterionic dyes for labeling in proteomic and other biological analyses | MONTANA STATE UNIVERSITY (US) | 2009-09-01 | — | — | US | disclosed |
| US-20070259333-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANALYSES | MONTANA STATE UNIVERSITY (US) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100203645-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANAYLSES | ACP1, ANXA5, CHAMP1 | PTGER1 4094/4885PTGER4 4164/4885PTGER3 3423/4885 |
| US-20100036133-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANALYSES | CHAMP1, ANXA5, ANXA3 | PTGER1 4007/4885PTGER4 3933/4885PTGER3 3663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.